Author Interviews, Brain Cancer - Brain Tumors / 05.05.2014
Recurrent Glioblastoma: Treatment with Cytomegalovirus Immunotherapy
MedicalResearch.com Interview with:
Dr Andrea Schuessler
QIMR Berghofer Medical Research Institute
Herston, Queensland 4006
MedicalResearch.com: What are the main findings of the study?
Dr . Schuessler: Recurrent glioblastoma is a very aggressive brain cancer and most patients do not survive much longer than 6 months. Our study has assessed a novel immunotherapy and treated 10 patients with late stage cancer. The treatment did not have any serious side effects and most of the patients have survived much longer than the expected 6 months. Importantly, four of the 10 patients have not shown signs of disease progression during the study period with one of them still being cancer free four years after the treatment.
(more…)